These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20431935)

  • 1. Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk.
    Zhang J; Dhakal IB; Lang NP; Kadlubar FF
    Cancer Causes Control; 2010 Sep; 21(9):1437-44. PubMed ID: 20431935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants.
    Zhang J; Dhakal IB; Greene G; Lang NP; Kadlubar FF
    Urology; 2010 Apr; 75(4):779-85. PubMed ID: 19914697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma carotenoids and prostate cancer: a population-based case-control study in Arkansas.
    Zhang J; Dhakal I; Stone A; Ning B; Greene G; Lang NP; Kadlubar FF
    Nutr Cancer; 2007; 59(1):46-53. PubMed ID: 17927501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Dossus L; Kaaks R; Canzian F; Albanes D; Berndt SI; Boeing H; Buring J; Chanock SJ; Clavel-Chapelon F; Feigelson HS; Gaziano JM; Giovannucci E; Gonzalez C; Haiman CA; Hallmans G; Hankinson SE; Hayes RB; Henderson BE; Hoover RN; Hunter DJ; Khaw KT; Kolonel LN; Kraft P; Ma J; Le Marchand L; Lund E; Peeters PH; Stampfer M; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D; Tumino R; Riboli E; Virtamo J; Weinstein SJ; Yeager M; Ziegler RG; Cox DG
    Carcinogenesis; 2010 Mar; 31(3):455-61. PubMed ID: 19965896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.
    Li H; Kantoff PW; Giovannucci E; Leitzmann MF; Gaziano JM; Stampfer MJ; Ma J
    Cancer Res; 2005 Mar; 65(6):2498-504. PubMed ID: 15781667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between plasma carotenoids and prostate cancer.
    Chang S; Erdman JW; Clinton SK; Vadiveloo M; Strom SS; Yamamura Y; Duphorne CM; Spitz MR; Amos CI; Contois JH; Gu X; Babaian RJ; Scardino PT; Hursting SD
    Nutr Cancer; 2005; 53(2):127-34. PubMed ID: 16573373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer.
    Nordström T; Van Blarigan EL; Ngo V; Roy R; Weinberg V; Song X; Simko J; Carroll PR; Chan JM; Paris PL
    Prostate; 2016 Mar; 76(4):339-48. PubMed ID: 26585352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase gene polymorphisms and prostate cancer risk.
    Lee KM; Kang D; Park SK; Berndt SI; Reding D; Chatterjee N; Chanock S; Huang WY; Hayes RB
    Carcinogenesis; 2009 Apr; 30(4):621-5. PubMed ID: 19168583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men.
    Fernandez P; de Beer PM; van der Merwe L; Heyns CF
    Carcinogenesis; 2008 Dec; 29(12):2347-50. PubMed ID: 18974063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cis-trans lycopene isomers, carotenoids, and retinol in the human prostate.
    Clinton SK; Emenhiser C; Schwartz SJ; Bostwick DG; Williams AW; Moore BJ; Erdman JW
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):823-33. PubMed ID: 8896894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lycopene intake and prostate cancer risk: effect modification by plasma antioxidants and the XRCC1 genotype.
    Goodman M; Bostick RM; Ward KC; Terry PD; van Gils CH; Taylor JA; Mandel JS
    Nutr Cancer; 2006; 55(1):13-20. PubMed ID: 16965236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
    Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
    Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between interleukin-8 rs4073 polymorphism and prostate cancer: A meta-analysis.
    Chen CH; Ho CH; Hu SW; Tzou KY; Wang YH; Wu CC
    J Formos Med Assoc; 2020 Jul; 119(7):1201-1210. PubMed ID: 31718853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men.
    Kopp TI; Friis S; Christensen J; Tjønneland A; Vogel U
    Cancer Genet; 2013; 206(7-8):266-78. PubMed ID: 23880210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects susceptibility and their circulating serum levels: An explorative study of prostate cancer patients in North Indian populations.
    Dwivedi S; Goel A; Khattri S; Mandhani A; Sharma P; Misra S; Pant KK
    Cytokine; 2015 Jul; 74(1):117-22. PubMed ID: 25892571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
    Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
    Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
    Gerstenberger JP; Bauer SR; Van Blarigan EL; Sosa E; Song X; Witte JS; Carroll PR; Chan JM
    Prostate; 2015 Jan; 75(1):60-9. PubMed ID: 25284284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial.
    Yang HP; Woodson K; Taylor PR; Pietinen P; Albanes D; Virtamo J; Tangrea JA
    Eur J Cancer Prev; 2006 Jun; 15(3):249-53. PubMed ID: 16679868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians.
    Fawzy MS; Elfayoumi AR; Mohamed RH; Fatah IRA; Saadawy SF
    Biochem Genet; 2016 Jun; 54(3):326-336. PubMed ID: 26920155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.